{Reference Type}: Case Reports {Title}: HRAS mutation as a diagnostic molecular analysis for epithelial-myoepithelial carcinoma of the parotid gland: A case report. {Author}: Yasuda T;Osaki M;Sugitani M; {Journal}: Clin Case Rep {Volume}: 11 {Issue}: 10 {Year}: 2023 Oct 暂无{DOI}: 10.1002/ccr3.8099 {Abstract}: HRAS mutations are frequent genetic alterations in epithelial-myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.